Повысь уровень инвестиционной грамотности и стань профессионалом с курсами от Societe Financiers!Подробнее
  1. Home
  2. Stock quotes
  3. AcelRx Pharmaceuticals
  4. Financial Ratios
AcelRx Pharmaceuticals logo
AcelRx Pharmaceuticals ACRX
$ 0.86 7.5%
mail-toReport an Error

Annual report 2024
added 03-31-2025

report update icon

AcelRx Pharmaceuticals Financial Ratios 2011-2025 | ACRX

Annual Financial Ratios AcelRx Pharmaceuticals

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -1.7 -0.7 0.1 -0.1 -4.6 -2.6 -3.0 -1.8 -2.7 -6.6 -8.7 -19.9 -3.4 -2.3

P/S

 - 18.8 2.7 1.0 34.6 59.5 66.8 11.4 6.8 8.3 55.8 15.8 47.3 43.5

EPS

 -0.5 -1.3 5.7 -5.9 -0.5 -0.7 -0.8 -1.1 -0.9 -0.6 -0.8 -0.6 -1.5 -1.2

EV (Enterprise Value)

 23.6 M 12.8 M 15.1 M 109 M 282 M 254 M 172 M 151 M 143 M 147 M 271 M 414 M 96 M 62.2 M

EBITDA per Share

 - -1.16 -3.2 -5.67 -0.459 -0.663 -0.602 -0.788 -0.66 -0.389 -0.847 -0.153 -1.32 -1.09

EV/EBITDA

 -3.0 -4.7 -2.8 -1.9 -1.6 -2.0 -4.2 -7.0 -64.5 -2.8 -3.1

PEG

 -0.01 -0.0 0.0 -0.0 -0.16 -0.15 -0.12 0.11 0.04 -0.23 0.29 -0.33 0.11 -0.02

P/B

 2.8 0.9 0.2 -0.1 -3.4 -3.3 33.8 -2.5 -22.1 4.8 6.2 6.4 3.3 2.7

P/CF

 -1.8 -0.7 -0.2 -0.1 -4.6 -2.5 -4.8 -2.8 -3.6 -7.5 -7.3 -123.4 -4.5 -2.7

ROE %

 -162.53 -130.43 218.92 97.79 72.43 128.54 -1108.61 141.08 808.64 -73.68 -71.49 -32.02 -98.57 -115.07

ROA %

 -71.31 -90.20 100.56 -45.06 -60.91 -58.28 -39.12 -68.18 -43.16 -19.09 -38.58 -21.29 -51.71 -49.22

ROCE %

 -190.63 -119.74 -115.98 100.20 -84.18 -69.72 -34.15 -62.50 -35.59 -16.69 -51.78 -6.46 -59.20 -58.66

Current Ratio

 1.8 3.2 1.8 0.7 2.7 5.3 6.8 4.6 8.7 9.3 5.6 15.2 4.3 4.9

DSO

 - - 16.5 51.5 42.8 82.9 68.0 70.0 122.7 62.3 - - - -

DIO

 - - - 133.1 98.4 176.7 78.4 32.7 63.8 96.1 - - - -

DPO

 58.9 67.8 - 236.2 165.6 92.2 190.0 48.8 46.2 321.9 - - - -

Operating Cycle

 - - 16.5 184.6 141.2 259.6 146.4 102.7 186.5 158.4 - - - -

Cash Conversion Cycle

 -58.9 -67.8 16.5 -51.6 -24.4 167.4 -43.6 54.0 140.3 -163.5 - - - -

All numbers in USD currency

Quarterly Financial Ratios AcelRx Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.13 -0.15 -0.16 - -0.08 -0.4 -0.75 - -0.94 8.58 -1.19 - -1.4 -0.08 -0.08 - -0.1 -0.08 -0.2 -0.18 -0.16 -0.16 -0.17 -0.18 -0.21 -0.2 -0.23 -0.2 -0.28 -0.29 -0.34 -0.21 -0.25 -0.24 -0.24 -0.24 0.11 -0.2 -0.23 -320 20 -240 -220 0.41 -0.26 -0.47 -0.34 -0.41 -0.38 -0.35 -0.36 -0.33 -0.3 -0.25 -0.3

EBITDA per Share

 - - - - - - -0.47 - -0.72 -1.73 -0.03 - -1.19 -0.08 -0.08 - -0.09 -0.07 -0.19 - -0.16 -0.16 -0.15 - -0.15 -0.13 -0.16 - -0.16 -0.2 -0.26 - -0.14 -0.16 -0.18 - 0.19 -0.16 -0.25 - -0.11 0.01 - - 0.01 0.01 - - 0.02 0.02 0.01 - 0.02 0.01 0.01

ROE %

 -96.46 -69.09 -80.98 -106.60 -131.40 -148.78 106.38 211.08 230.54 274.80 88.97 79.63 95.65 92.20 76.68 56.43 91.26 105.98 124.09 128.54 -201.55 -525.21 -803.03 -1108.61 -786.26 -457.69 -174.07 141.08 295.42 473.42 645.48 808.64 595.38 397.04 162.35 -73.68 -71.45 -85.32 -81.12 -71.49 -17.58 -34.04 -35.22 -32.02 -87.40 -97.73 -95.14 -98.57 -103.97 -111.59 -117.60 -115.07 -32.98 -27.27 -18.34

ROA %

 -50.93 -40.81 -50.07 -61.50 -75.47 -83.61 66.93 99.86 88.27 90.65 -47.61 -34.22 -47.69 -49.57 -47.16 -47.46 -63.24 -63.71 -67.33 -58.28 -52.91 -49.31 -44.47 -39.12 -41.78 -48.67 -57.21 -68.18 -64.77 -58.95 -52.76 -43.16 -41.73 -26.36 -22.23 -19.09 -26.83 -30.02 -35.29 -38.59 -6.45 -17.21 -20.83 -21.29 -53.75 -57.06 -52.36 -51.71 -51.01 -51.81 -52.33 -49.22 -14.11 -11.66 -7.85

ROCE %

 - - -37.41 -74.82 -99.18 -86.13 -127.08 -52.42 -32.35 12.08 80.86 81.37 97.58 93.72 78.15 56.90 89.57 106.04 126.04 94.68 -124.65 -376.66 -577.10 -581.94 -557.67 -314.07 -118.66 84.57 234.00 359.15 487.86 465.04 486.49 358.52 178.06 -37.50 -48.37 -80.69 -56.16 -10.86 -10.86 - - - - - - - - - - - - - -

Current Ratio

 1.9 2.0 2.3 3.2 4.7 2.4 2.2 1.9 2.3 2.4 0.7 0.7 0.6 0.7 0.8 0.5 0.5 0.5 0.5 0.7 0.7 0.7 0.7 1.0 1.0 1.0 1.0 0.7 0.7 0.7 0.7 0.9 0.9 0.9 0.9 1.4 1.4 1.4 1.4 2.2 2.2 2.2 2.2 3.0 3.0 3.0 3.0 2.1 2.1 2.1 2.1 1.8 1.8 1.8 1.8

DSO

 - - - - - - - - 78.8 43.9 35.5 - 6.3 78.5 115.5 - 42.4 19.8 126.1 83.0 64.8 41.9 82.8 7.3 11.9 5.5 210.4 189.0 94.1 52.6 108.1 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - 142.3 101.3 125.5 - 303.4 122.0 133.6 - 80.2 108.3 148.6 - 140.0 166.1 153.9 - 89.1 104.0 74.1 - 43.0 24.6 34.4 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - 353.1 266.4 281.4 - 433.3 227.1 262.0 - 134.9 182.3 134.6 - 73.1 86.7 140.6 - 215.9 252.2 143.1 - 64.0 36.7 33.0 - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - 221.2 145.2 161.0 - 309.7 200.5 249.0 - 122.5 128.1 274.7 83.0 204.8 208.0 236.7 7.3 100.9 109.5 284.6 189.0 137.1 77.2 142.5 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - -131.9 -121.2 -120.5 - -123.6 -26.5 -13.0 - -12.4 -54.2 140.1 83.0 131.8 121.3 96.1 7.3 -115.0 -142.7 141.5 189.0 73.0 40.5 109.5 82.7 158.1 117.5 137.5 173.3 19.4 155.8 828.3 - - - - - - - - - - - - - - - -

All numbers in USD currency